NIH Grant Panels Meet Behind Closed Doors to Judge Applications
Published Date: 10/20/2026
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in November 2026 to review grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants and small businesses in health research should note these important review dates.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Grant reviews closed to protect trade secrets
If you applied for an NIH grant, your application will be reviewed in meetings that are closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6). The notice says the discussions could disclose confidential trade secrets or personal information, and those details will be protected during the review.
Multiple virtual review panels on Nov 17-18, 2026
If you are a scientist or small business applying for NIH funding, several Center for Scientific Review panels (including multiple panels labeled “Small Business”) will meet virtually to review and evaluate grant applications on November 17-18, 2026. Meetings are generally scheduled starting at 10:00 a.m., with many ending around 6:00 p.m. and some panels running later.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-21525, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in November 2026 to review important grant applications related to health research. These meetings protect private info and trade secrets while deciding which projects get funding. Scientists and small businesses applying for grants will be affected, with no changes to timing or money announced.
2026-21527, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for scientific projects, especially in biophysics, immunology, neurodegenerative disorders, and anti-infective therapies. No public access is allowed to protect private and sensitive information, but these reviews help decide who gets research money.
2026-21526, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and decide on grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for important health research. If you’re involved in health or small business research grants, these reviews could impact your funding timeline and opportunities.
2026-21022, Center For Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and decide on grant applications related to cancer, chemistry, kidney health, and small business health projects. These meetings protect private info and trade secrets while helping decide who gets research funding. Scientists and small businesses applying for grants should note these dates for their funding chances.
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
Previous / Next Documents
Previous: 2026-21394, Determination and Certification With Respect to the Child Soldiers Prevention Act (CPSA) of 2008
The U.S. government is easing some rules to keep helping certain countries like the Central African Republic, DRC, Ethiopia, Nigeria, Somalia, Venezuela, Yemen, and Russia with military training, equipment, and peacekeeping support. This change means these countries are recognized for making progress against using child soldiers, so the U.S. can continue its support without full restrictions. These waivers take effect now and keep important aid flowing without extra costs.
Next: 2026-21396, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public virtual meeting on January 20, 2027, to discuss updates and future plans. After a short open session, they'll review grant applications in a closed session to protect privacy and trade secrets. Researchers and the public interested in diabetes, digestive, or kidney diseases should note this important date for potential funding and updates.